BJ
CYTK icon

BlackRock Japan’s Cytokinetics CYTK Stock Holding History

BlackRock Japan’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-720
Closed -$7K – 1335
2016
Q2 		$7K Sell
720
-802
-53% -$6.58K ﹤0.01% 1311
2016
Q1 		$11K Hold
1,522
– – ﹤0.01% 1273
2015
Q4 		$16K Sell
1,522
-901
-37% -$8.84K ﹤0.01% 1198
2015
Q3 		$16K Buy
+2,423
New +$16.5K ﹤0.01% 1118
2015
Q1 		– Sell
-3,390
Closed -$27K – 1309
2014
Q4 		$27K Sell
3,390
-1,771
-34% -$7.6K ﹤0.01% 1183
2014
Q3 		$18K Hold
5,161
– – ﹤0.01% 1171
2014
Q2 		$25K Sell
5,161
-6,331
-55% -$38.6K ﹤0.01% 1130
2014
Q1 		$109K Buy
11,492
+2,232
+24% +$20.2K ﹤0.01% 1038
2013
Q4 		$60K Buy
+9,260
New +$60.8K ﹤0.01% 1103

Other funds holding CYTK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock Japan's CYTK Position: Q3 2016 in Review

BlackRock Japan sold out of Cytokinetics (CYTK) in Q3 2016, closing a stake of 720 shares — an estimated $7K sold.

BlackRock Japan first reported a position in CYTK in Q4 2013 and held it in 9 quarters. The position peaked at $109K in Q1 2014. 91 funds tracked by Wall St. Rank hold CYTK as of Q3 2016.

  • BlackRock Japan reported no remaining Cytokinetics position as of Q3 2016 after selling out during the quarter.
  • BlackRock Japan sold 720 Cytokinetics shares in Q3 2016, an estimated $7K.
  • BlackRock Japan first reported a position in Cytokinetics in Q4 2013 and held it in 9 quarters.
  • BlackRock Japan's Cytokinetics position peaked at $109K in Q1 2014.
  • 91 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2016.

Based on BlackRock Japan's 13F filing for Q3 2016, filed 8 Nov 2016.